[go: up one dir, main page]

DK3102185T3 - Nanosuspension af naturlige materialer og fremgangsmåde til fremstilling deraf - Google Patents

Nanosuspension af naturlige materialer og fremgangsmåde til fremstilling deraf Download PDF

Info

Publication number
DK3102185T3
DK3102185T3 DK15702278.1T DK15702278T DK3102185T3 DK 3102185 T3 DK3102185 T3 DK 3102185T3 DK 15702278 T DK15702278 T DK 15702278T DK 3102185 T3 DK3102185 T3 DK 3102185T3
Authority
DK
Denmark
Prior art keywords
nanosus
suspension
procedure
natural materials
natural
Prior art date
Application number
DK15702278.1T
Other languages
English (en)
Inventor
Werner Brand
Original Assignee
Apurano Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apurano Pharmaceuticals Gmbh filed Critical Apurano Pharmaceuticals Gmbh
Application granted granted Critical
Publication of DK3102185T3 publication Critical patent/DK3102185T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/748Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/071Agaricus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/20Ingredients acting on or related to the structure
    • A23V2200/25Nanoparticles, nanostructures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK15702278.1T 2014-02-03 2015-02-03 Nanosuspension af naturlige materialer og fremgangsmåde til fremstilling deraf DK3102185T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14153705 2014-02-03
EP2014064449 2014-07-07
PCT/EP2015/052202 WO2015114164A1 (en) 2014-02-03 2015-02-03 Nanosuspension of natural materials and preparation method thereof

Publications (1)

Publication Number Publication Date
DK3102185T3 true DK3102185T3 (da) 2021-10-04

Family

ID=52444306

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15702278.1T DK3102185T3 (da) 2014-02-03 2015-02-03 Nanosuspension af naturlige materialer og fremgangsmåde til fremstilling deraf

Country Status (22)

Country Link
US (1) US10213382B2 (da)
EP (1) EP3102185B1 (da)
JP (2) JP6751672B2 (da)
KR (1) KR20160118317A (da)
CN (1) CN106102719A (da)
AU (1) AU2015212726B2 (da)
CA (1) CA2938552C (da)
CY (1) CY1124656T1 (da)
DK (1) DK3102185T3 (da)
ES (1) ES2891151T3 (da)
HR (1) HRP20211513T1 (da)
HU (1) HUE056398T2 (da)
LT (1) LT3102185T (da)
MX (1) MX375742B (da)
NZ (1) NZ723631A (da)
PL (1) PL3102185T3 (da)
RS (1) RS62381B1 (da)
RU (1) RU2695325C1 (da)
SA (1) SA516371597B1 (da)
SI (1) SI3102185T1 (da)
WO (1) WO2015114164A1 (da)
ZA (1) ZA201604743B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ723631A (en) * 2014-02-03 2017-08-25 Apurano Pharmaceuticals Gmbh Nanosuspension of natural materials and preparation method thereof
CA2994620C (en) * 2015-08-04 2021-07-06 Apurano Life Sciences Gmbh Nanosuspension containing particles and extract of natural materials
EP3744181A4 (en) * 2018-03-27 2021-04-28 Mizkan Holdings Co., Ltd. SOLID FAT COMPOSITION CONTAINING A PLANT, ASSOCIATED PRODUCTION PROCESS AND APPEARANCE AND TASTE IMPROVEMENT PROCESS
WO2020014367A1 (en) * 2018-07-10 2020-01-16 Applied Lifesciences And Systems Poultry, Inc. Systems and methods of preparing and delivering gels
CN109432018A (zh) * 2018-12-25 2019-03-08 中国人民解放军第四军医大学 难溶性药物的纳米混悬液及其制备方法和应用
KR102116022B1 (ko) * 2019-07-16 2020-05-27 (주)코이즈 고농도의 산소를 함유하는 미세소구체가 포함된 화장료 조성물 및 이의 제조방법
BR112022010439A2 (pt) 2020-01-06 2022-09-06 Cannaxan Gmbh Preparação e uso de nanoformulação de cannabis
CN115998703B (zh) * 2022-12-14 2024-09-06 迪沙药业集团有限公司 一种地榆组合物及其制备方法
US11832614B1 (en) 2023-04-28 2023-12-05 King Faisal University Method of inhibiting mycotoxin growth using Arthrospira platensis nanoparticles

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3502153A1 (de) 1985-01-23 1986-07-24 Röben Kolloid Entwicklung GmbH & Co KG, 2932 Zetel Kolloidator zum kolloidieren von fliessfaehigen materialien
DE4137540A1 (de) * 1991-11-14 1993-05-19 Steigerwald Arzneimittelwerk Verwendung von praeparaten der curcuma-pflanzen
JPH05221852A (ja) * 1992-02-18 1993-08-31 L T T Kenkyusho:Kk 制ガン剤の新規製剤調製方法
ZA9711731B (en) * 1996-12-31 1998-07-01 Monsanto Co Aqueous glycerol formulations of somatotropin
US20050107582A1 (en) 2003-07-30 2005-05-19 Alfred Wong Method for the preparation of phytosterols from tall oil pitch
US20120042886A1 (en) * 1998-03-11 2012-02-23 Hanna Piskorz Method of producing a nicotine medicament and a medicament made by the method
DE19832304A1 (de) * 1998-07-17 2000-01-20 Reiner Weichert Verfahren und Vorrichtung zur Ultrafein-Mahlung von festen Materialien
US6375986B1 (en) * 2000-09-21 2002-04-23 Elan Pharma International Ltd. Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate
WO2001001962A1 (en) * 1999-07-05 2001-01-11 Idea Ag. A method for the improvement of transport across adaptable semi-permeable barriers
JP4752233B2 (ja) * 2001-04-27 2011-08-17 味の素株式会社 免疫賦活剤
TWI300714B (en) 2001-04-27 2008-09-11 Ajinomoto Kk Immunopotentiators
ES2253566T3 (es) 2001-09-28 2006-06-01 Glycomed Sciences Limited Procedimiento de extraccion con disolventes.
CN1416847A (zh) * 2001-11-07 2003-05-14 焦柏忠 纳米级西洋参制品及其制作方法
IL146737A (en) * 2001-11-26 2010-02-17 Lycored Natural Prod Ind Ltd Method for protecting lycopene dispersed in tomato fibers
ATE505198T1 (de) * 2002-02-28 2011-04-15 Heitland & Petre Internat Gmbh Mikro-/nanopartikel aus lipidhaltigen marinen organismen für pharmazie und kosmetik
WO2003103633A1 (en) * 2002-06-10 2003-12-18 Elan Pharma International, Ltd. Nanoparticulate sterol formulations and sterol combinations
US20120156309A1 (en) * 2007-09-19 2012-06-21 Eckert C Edward Using Aqueous Oxygenation to Improve Animal Health & Wellness
US20060062926A1 (en) * 2004-05-17 2006-03-23 Richardson H W Use of sub-micron copper salt particles in wood preservation
CA2598441A1 (en) 2005-02-24 2006-08-31 Elan Pharma International Limited Nanoparticulate formulations of docetaxel and analogues thereof
DE102005011786A1 (de) * 2005-03-11 2006-09-14 Pharmasol Gmbh Verfahren zur Herstellung ultrafeiner Submicron-Suspensionen
CN100341785C (zh) * 2005-07-27 2007-10-10 湖州吴兴恒联碳酸钙厂 亚微米级重质碳酸钙的制备方法
JP5374869B2 (ja) * 2007-12-25 2013-12-25 三菱化学株式会社 セルロース繊維複合体
US8012573B2 (en) 2007-12-21 2011-09-06 Mitsubishi Chemical Corporation Fiber composite
JP5562229B2 (ja) 2008-03-17 2014-07-30 サントリー食品インターナショナル株式会社 呈味改善剤及びこれを含む茶飲料
JP5448511B2 (ja) * 2008-03-31 2014-03-19 三栄源エフ・エフ・アイ株式会社 ウコン色素組成物及びその調製方法
JP2010083839A (ja) * 2008-10-02 2010-04-15 Sanei Gen Ffi Inc ミルクカルシウムの分散安定化方法並びにその製剤
KR101160801B1 (ko) * 2010-05-27 2012-06-29 서용일 고형 보조 첨가제
AU2011262840B2 (en) * 2010-06-08 2015-02-05 Asahi Group Holdings, Ltd. Lipid metabolism-improving agent
TWI425914B (zh) * 2011-03-21 2014-02-11 Food Industry Res & Dev Inst 含高濃度奈米/次微米疏水性機能化合物之水相分散液之製備方法
AU2013259150B2 (en) * 2012-05-11 2016-07-14 Formosa Pharmaceuticals, Inc. Organic compound nanopowder, production method therefor, and suspension
NZ723631A (en) * 2014-02-03 2017-08-25 Apurano Pharmaceuticals Gmbh Nanosuspension of natural materials and preparation method thereof
EP3129024A4 (en) * 2014-04-08 2017-11-22 Sansa Corporation (Barbados) Inc. Nicotine formulations and methods of making the same

Also Published As

Publication number Publication date
JP2017505814A (ja) 2017-02-23
AU2015212726B2 (en) 2018-02-01
CY1124656T1 (el) 2022-07-22
WO2015114164A1 (en) 2015-08-06
HRP20211513T1 (hr) 2021-12-24
EP3102185B1 (en) 2021-07-14
JP6751672B2 (ja) 2020-09-09
US20160346201A1 (en) 2016-12-01
NZ723631A (en) 2017-08-25
LT3102185T (lt) 2022-01-10
CA2938552C (en) 2021-07-13
RS62381B1 (sr) 2021-10-29
JP2018172394A (ja) 2018-11-08
SA516371597B1 (ar) 2020-04-29
HUE056398T2 (hu) 2022-02-28
PL3102185T3 (pl) 2021-12-27
EP3102185A1 (en) 2016-12-14
SI3102185T1 (sl) 2022-01-31
AU2015212726A1 (en) 2016-09-15
MX375742B (es) 2025-03-06
CA2938552A1 (en) 2015-08-06
MX2016010037A (es) 2017-10-26
RU2695325C1 (ru) 2019-07-23
US10213382B2 (en) 2019-02-26
ES2891151T3 (es) 2022-01-26
ZA201604743B (en) 2017-09-27
KR20160118317A (ko) 2016-10-11
CN106102719A (zh) 2016-11-09

Similar Documents

Publication Publication Date Title
IL271025A (en) Multibiotic agents and methods of using the same
DK3353210T3 (da) Anti-TIGIT-antistoffer og fremgangsmåder til anvendelse
DK3215532T3 (da) Anti-TIM3-antistoffer og fremgangsmåder til anvendelse
DK3445388T3 (da) Materialer og fremgangsmåder til behandling af hæmoglobinopatier
DK3653221T3 (da) Anti-pvrig-antistoffer og anvendelsesfremgangsmåder
DK3356404T3 (da) Anti-pd1-antistoffer og fremgangsmåder til anvendelse
DK3436048T3 (da) Neoantigener og fremgangsmåder til anvendelse deraf
DK3317284T3 (da) Benzoxazepin-oxazolidinonforbindelser og fremgangsmåder til anvendelse
DK3230319T3 (da) Anti-PD-1-antistoffer og fremgangsmåder til anvendelse deraf
DK3303386T3 (da) Anti-Tau-antistoffer og fremgangsmåder til anvendlelse
DK3209308T3 (da) Aktiverede bifidobakterier og fremgangsmåder til anvendelse deraf
DK3204413T3 (da) Bærerantistofsammensætninger og fremgangsmåder til fremstilling og anvendelse heraf
DK3102673T3 (da) Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
DK3234133T3 (da) Crispr-baserede sammensætninger og fremgangsmåder til anvendelse
DK3229838T3 (da) Anti-C10orf54-antistoffer og anvendelser deraf
DK3149042T3 (da) PD-L1-antistoffer og anvendelser deraf
DK3240785T3 (da) Småmolekylede hæmmere af laktasedehydrogenase og fremgangsmåder til brug deraf
DK3148579T3 (da) Anti-gitr antistoffer og fremgangsmåder til anvendelse deraf
DK3126388T3 (da) Anti-EGFRvIII-antistoffer og anvendelser deraf
DK3160964T3 (da) Arylreceptormodulatorer og fremgangsmåder til fremstilling og brug af samme
DK3185868T3 (da) Hidtil ukendte ULK1-inhibitorer og fremgangsmåder til anvendelse af samme
DK3212189T3 (da) Substituerede chromaner og fremgangsmåde til anvendelse deraf
DK3224603T3 (da) Nordning og fremgangsmåde til materialekarakteristik
DK3394065T3 (da) Tetrahydropyranyl-amino-pyrrolopyrimidinon og fremgangsmåder til anvendelse deraf
DK3144001T3 (da) Sammensætninger af selenoorganiske forbindelser og fremgangsmåder til anvendelse deraf